Journal
CANCER AND METASTASIS REVIEWS
Volume 40, Issue 4, Pages 1177-1201Publisher
SPRINGER
DOI: 10.1007/s10555-021-10009-z
Keywords
Pheochromocytoma; Paraganglioma; Succinate dehydrogenase; SDH; Model organisms
Categories
Funding
- Eotvos Lorand University
- Phaeo Para Cancer Charity, UK
- Hungarian Scientific Research Fund (OTKA) [K134285]
Ask authors/readers for more resources
This article reviews the pathophysiological studies on pheochromocytoma (PHEO) and paraganglioma (PGL) caused by mutations in succinate dehydrogenase (SDH) subunit B (SDHB) gene, and the contributions of different model organisms to our understanding of SDH dysfunction.
Pheochromocytoma (PHEO) and paraganglioma (PGL) (together PPGL) are tumors with poor outcomes that arise from neuroendocrine cells in the adrenal gland, and sympathetic and parasympathetic ganglia outside the adrenal gland, respectively. Many follow germline mutations in genes coding for subunits of succinate dehydrogenase (SDH), a tetrameric enzyme in the tricarboxylic acid (TCA) cycle that both converts succinate to fumarate and participates in electron transport. Germline SDH subunit B (SDHB) mutations have a high metastatic potential. Herein, we review the spectrum of model organisms that have contributed hugely to our understanding of SDH dysfunction. In Saccharomyces cerevisiae (yeast), succinate accumulation inhibits alpha-ketoglutarate-dependent dioxygenase enzymes leading to DNA demethylation. In the worm Caenorhabditis elegans, mutated SDH creates developmental abnormalities, metabolic rewiring, an energy deficit and oxygen hypersensitivity (the latter is also found in Drosophila melanogaster). In the zebrafish Danio rerio, sdhb mutants display a shorter lifespan with defective energy metabolism. Recently, SDHB-deficient pheochromocytoma has been cultivated in xenografts and has generated cell lines, which can be traced back to a heterozygous SDHB-deficient rat. We propose that a combination of such models can be efficiently and effectively used in both pathophysiological studies and drug-screening projects in order to find novel strategies in PPGL treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available